IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Feb 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-16

Reporting Person: Claflin Bruce L. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-16	Common Stock	M	5902	$85	Acquired	6206	Direct
2021-02-16	Common Stock	M	1125	$160.28	Acquired	7331	Direct
2021-02-16	Common Stock	S	6745	$536.8856	Disposed	586	Direct
2021-02-16	Common Stock	S	586	$537.1931	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-16	Non-Qualified Stock Option (right-to-buy)	$85	M	5902	Disposed	2026-05-03	Common Stock (5902)	Direct
2021-02-16	Non-Qualified Stock Option (right-to-buy)	$160.28	M	1125	Disposed	2027-05-02	Common Stock (1125)	Direct

Footnotes

F1: Represents the weighted average price of the shares sold ranging from a low of $536.13 to a high of $537.125 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F2: Represents the weighted average price of the shares sold ranging from a low of $537.15 to a high of $537.23 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

F3: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders.

F4: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 3, 2018.

F5: Not applicable.